Breast Cancer Market By Global Top Key Players, Share, Size, Demand, Opportunities, Sale Area, Revenue Analysis Forecast Outlook 2028

 

Breast cancer is defined as a type of cancer where a lump is formed in the breast, and red patches appear on the skin when cells of breast tissue become cancerous. Market Research Future (MRFR) has published and released a research report about the global breast cancer market that anticipates great boost with 9.2% CAGR (Compound Annual Growth Rate) for this market between 2017 and 2023. Observing the market structure, this report evaluates the future growth potential of the market and analyzes the approaches of the key players in the market. It also follows the competitive developments such as joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market.

The key factors that drive this market include the adoption of an unhealthy lifestyle, exposure to harmful radiation, increasing female geriatric population, increasing governmental initiatives, and increasing number of females suffering from breast cancer. However, there are some factors that can hamper the growth of this market. Such factors include adverse effects associated with the therapy, high cost of the treatment, and long approval time for the drugs. 

The global Breast Cancer Market has been segmented on the basis of end user, treatment, type, and lastly, region. Based on end users, this market has been segmented

on the basis of hospital pharmacies, private pharmacies, and others.

The treatment-based segmentation of this market covers biologic therapy, chemotherapy, hormone therapy, surgery & radiation therapy, and targeted therapy.

Chemotherapy has been further segmented into alkylating agents, antimetabolites, anthracyclines, and taxanes. The targeted therapy has been further segmented into monoclonal antibodies and tyrosine kinase inhibitors.

By type-based segmentation, the market has been segmented into invasive ductal carcinoma, invasive lobular carcinoma, others.

Segmentation:

The regional segmentation of the global liquid biopsy breast cancer market segments the market into regional markets namely The Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA). The Americas dominate the global market. Changing lifestyle and increasing prevalence of breast cancer in the Americas has driven the growth of the market. In the Americas, North America is a bigger market than South America because more advanced medical facilities being available in North America and many key players in the market is based in Canada and the United States of America (USA).

The second biggest market is in Europe. Due to the reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. The most significant country-based markets in Western Europe are France, Germany, Italy, Spain, and the United Kingdom (UK). Technological advancement, increased life expectancy and increasing disposable income regarding healthcare expenditure of people are driving the market growth in the Americas and Europe. 

According to the report, Asia Pacific is expected to emerge as the fastest growing market during the forecast period. The most significant country-specific markets in the Asia Pacific region are Australia, China, Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a small market. The market is low due to lack of awareness, lack of education, lack of technological development, political instability, poor healthcare, and healthcare not considered a priority by most governments. The most important country-specific markets in this region are Kuwait, Oman, Saudi Arabia, Qatar, and the United Arab Emirates (UAE).

Key Players

The key players in the global Breast cancer market include Accord Healthcare, Inc. (India), Actavis Inc. (USA), Apthera Inc (UK), Astellas (Japan), AstraZeneca (UK), Bayer AG (Germany), BioNumerik Pharmaceuticals (USA), Bipar Sciences (USA), Bristol-Myers Squibb Company (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche (Switzerland), Genentech (USA), Gilead Sciences Inc. (USA), GlaxoSmithKline (UK), Hospira, Inc. (USA), Novartis AG (Switzerland), Oncogenex (USA), Oncothyreon Inc (USA), Pfizer (USA), Puma Biotechnology (USA), Sanofi S.A. (USA), Sun Pharmaceutical Industries Ltd (India), and Teva Pharmaceutical Industries (Israel).

Latest Industrial News

·         Roberta Lombardi, founder, and CEO of Infinite Beauty has designed a new bra to make breast cancer patients feel normal. 11 SEP 2018

·         Biotechnology Company, Oncolytic Biotech, has announced a clinical collaboration with an academic research group. This collaboration is dedicated to clinical and translational research in breast cancer, SOLTI. 11 SEP 2018

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

 

 

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more